ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 270 filers reported holding ALKERMES PLC in Q2 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,953,000 | -45.5% | 33,280 | -40.3% | 0.95% | -49.1% |
| Q2 2015 | $3,584,000 | +30.6% | 55,700 | +23.8% | 1.86% | +27.9% |
| Q1 2015 | $2,744,000 | -47.9% | 45,000 | -50.0% | 1.46% | -4.6% |
| Q4 2014 | $5,270,000 | +173.2% | 90,000 | +100.0% | 1.53% | +57.5% |
| Q3 2014 | $1,929,000 | -14.8% | 45,000 | 0.0% | 0.97% | +52.0% |
| Q2 2014 | $2,265,000 | +14.2% | 45,000 | 0.0% | 0.64% | -34.8% |
| Q1 2014 | $1,984,000 | +8.4% | 45,000 | 0.0% | 0.98% | +9.8% |
| Q4 2013 | $1,830,000 | +21.0% | 45,000 | 0.0% | 0.89% | -7.4% |
| Q3 2013 | $1,513,000 | – | 45,000 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |